Skip Navigation


NDT Advance Access originally published online on July 7, 2007
Nephrology Dialysis Transplantation 2007 22(12):3568-3572; doi:10.1093/ndt/gfm424
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/12/3568    most recent
gfm424v2
gfm424v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Spiegel, D. M.
Right arrow Articles by Block, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spiegel, D. M.
Right arrow Articles by Block, G. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org



Factors associated with mortality in patients new to haemodialysis

David M. Spiegel1, Paolo Raggi2, Gerard Smits3 and Geoffrey A. Block4

1Division of Renal Diseases and Hypertension, University of Colorado HSC, Denver, CO, 2Division of Cardiology, Emory University School of Medicine, Atlanta, GA, 3Computer and Statistical Consultants, Inc., Santa Barbara, CA and 4Denver Nephrology, Denver, CO, USA

Correspondence and offprint requests to: David M. Spiegel, MD, University of Colorado Health Sciences Center, 4200 E. 9th Avenue, Box C-281, Denver, CO 80262, USA. Email: david.spiegel{at}uchsc.edu



  Abstract

Background. Patients receiving dialysis therapy for end-stage kidney failure have a high cardiovascular mortality that can only be partially explained by traditional risk factors.

Methods. This study was a post hoc analysis of a prospectively gathered data set from a randomized trial comparing outcomes in new haemodialysis patients treated with sevelamer or calcium-containing phosphate binders. Patients were followed from the time of enrollment until death or censor on 31 December 2005. Median follow-up was 3.6 years. Demographics, cardiovascular risk factors, laboratory data, medication use and severity of vascular calcification were available at baseline and over the first 18 months of dialysis.

Results. Baseline predictors of mortality included age, creatinine, heart rate, iPTH, C-reactive protein (CRP), coronary and aortic calcium scores and the presence of aortic valve calcification. Over the first 18 months, averages of diastolic blood pressure, BUN, creatinine, albumin, phosphorus, iPTH and CRP were all significantly different between survivors and non-survivors. A stepwise multivariable adjusted Cox regression model demonstrated that low BUN and albumin and high CRP along with the use of calcium-containing phosphate binders (rather than sevelamer) were the strongest predictors of mortality in patients new to haemodialysis.

Conclusions.These findings suggest that non-traditional risk factors, such as inflammation and malnutrition measured during the first 18 months of dialysis, are important determinates of survival in new dialysis patients. In addition, the unique risk factor for dialysis patients, the use of calcium-containing phosphate binders, was associated with a higher mortality rate in patients new to dialysis.

Keywords: ESRD; malnutrition inflammation; mortality; phosphate binders; haemodialysis; vascular calcification

Received for publication: 20.12.06
Accepted in revised form: 5. 6.07


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
S. A. Bakkaloglu, A. Saygili, L. Sever, A. Noyan, S. Akman, M. Ekim, N. Aksu, B. Doganay, N. Yildiz, A. Duzova, et al.
Assessment of cardiovascular risk in paediatric peritoneal dialysis patients: a Turkish Pediatric Peritoneal Dialysis Study Group (TUPEPD) report
Nephrol. Dial. Transplant., November 1, 2009; 24(11): 3525 - 3532.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
L. Labriola, P. Wallemacq, B. Gulbis, and M. Jadoul
The impact of the assay for measuring albumin on corrected ('adjusted') calcium concentrations
Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1834 - 1838.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. S. DeLoach, M. M. Joffe, X. Mai, S. Goral, and S. E. Rosas
Aortic calcification predicts cardiovascular events and all-cause mortality in renal transplantation
Nephrol. Dial. Transplant., April 1, 2009; 24(4): 1314 - 1319.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. D. Cohen, P. L. Kimmel, R. Neff, L. Agodoa, and K. C. Abbott
Association of Incident Gout and Mortality in Dialysis Patients
J. Am. Soc. Nephrol., November 1, 2008; 19(11): 2204 - 2210.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
P. Stenvinkel, J. J. Carrero, J. Axelsson, B. Lindholm, O. Heimburger, and Z. Massy
Emerging Biomarkers for Evaluating Cardiovascular Risk in the Chronic Kidney Disease Patient: How Do New Pieces Fit into the Uremic Puzzle?
Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 505 - 521.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.